Clinical trial
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential…
NCT00380289 · University of Cambridge, Other · Unknown status
Key facts
| NCT number | NCT00380289 |
|---|---|
| Title | Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension |
| Official title | Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension |
| Lead sponsor | University of Cambridge, Other |
| Collaborators | Cambridge University Hospitals NHS Foundation Trust |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | Thiazide and beta blocker |
| Enrollment | 66 |
| Start date | Sep 1, 2006 |
| First posted | Sep 25, 2006 |
| Last update posted | Sep 25, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: